When did Olema Pharmaceuticals, Inc. report Q4 2024 earnings?

Olema Pharmaceuticals, Inc. (OLMA) reported Q4 2024 earnings on March 18, 2025 before market open.

What were Olema Pharmaceuticals, Inc.'s Q4 2024 revenue and EPS?

Olema Pharmaceuticals, Inc. reported diluted EPS of $-0.51 for Q4 2024.

Did Olema Pharmaceuticals, Inc. beat estimates in Q4 2024?

EPS beat the consensus estimate of $-0.63 by $0.12.

Where can I find Olema Pharmaceuticals, Inc.'s Q4 2024 SEC filings?

You can read the 10-K periodic report (0000950170-25-041204) directly on SEC EDGAR. The filing index links above go to sec.gov.

Olema Pharmaceuticals, Inc. OLMA Q4 2024 Annual earnings

Reported March 18, 2025 · Before market open

Diluted EPS-$0.51Beat by $0.12

EPS estimate-$0.63

Next report

Aug 10, 2026 (In 4 weeks)

EPS estimate-$0.53

Financials

Q4 2024

Income statement

See full

Operating income-$36.8M-20.9%

Net income-$33.6M-25.4%

EPS (diluted)-$0.40+16.7%

Balance sheet

See full

Cash & equivalents$139.5M+104%

Total debt$1.4M-40.9%

Total equity$409.0M+61.1%

Total assets$451.0M+62.8%

Cash flow

See full

Operating cash flow-$26.3M-42.3%

Free cash flow-$26.3M—

Valuation & ratios

Valuation

as of 12/31/24

See full

Market cap$430.29M-44.0%

Enterprise value$292.24M-58.4%

Returns & leverage

See full

Return on equity-39.1%-3.1pp

Debt / equity0×0.0×

Current ratio10.5×-1.8×

Versus estimates

Diluted EPS

Q1 2026-$0.52In line Q4 2025-$0.50Beat by $0.01 Q3 2025-$0.49Miss by $0.05 Q2 2025-$0.51Miss by $0.08 Q1 2025-$0.36Beat by $0.13

Q4 2024-$0.51Beat by $0.12

Ask the moment Olema Pharmaceuticals, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Olema Pharmaceuticals, Inc. report Q4 2024 earnings?: Olema Pharmaceuticals, Inc. (OLMA) reported Q4 2024 earnings on March 18, 2025 before market open.
What were Olema Pharmaceuticals, Inc.'s Q4 2024 revenue and EPS?: Olema Pharmaceuticals, Inc. reported diluted EPS of $-0.51 for Q4 2024.
Did Olema Pharmaceuticals, Inc. beat estimates in Q4 2024?: EPS beat the consensus estimate of $-0.63 by $0.12.
Where can I find Olema Pharmaceuticals, Inc.'s Q4 2024 SEC filings?: You can read the 10-K periodic report (0000950170-25-041204) directly on SEC EDGAR. The filing index links above go to sec.gov.